|
Prof Hedy Kindler – University of Chicago, USA
|
Prof Hedy Kindler – University of Chicago, USA
Prof Hedy Kindler outlines the results of a randomised phase II trial investigating the use of conatumumab or AMG 479 as a treatment for pancreatic cancer. Both monoclonal antibodies had positive effects and led to an increased length of progression free survival, however this increase was greater with AMG479. The side effects were minimal and the team will shortly be starting a phase III trial.
Video Length: 0
Date Found: June 25, 2010
Date Produced:
View Count: 0
|
|
|
|
|
I got punched by an old guy, for farting near his wife. Read MoreComic book creator Stan Lee talks the future of the medium in the digital age. Panelists Zachary... Read MoreThe U.S. launch of Spotify is still on music lovers' minds. Join Zachary Levi, from NBC’s... Read MoreTuesday: Rupert Murdoch testifies before Parliament on the hacking scandal that brought down "News... Read MoreAfter a long slump, the home construction industry may be showing signs of life. But as Bill... Read More | 1 2 3 4 5 |
|
|
|